Our prior work showed that RCC CD8+ TILs have metabolic defects, and we tested here whether the costimulation known in classical regulation of T cells to increase glycolysis could overcome this metabolic defect seen in patient TILs (5, 18). Here, CD8A is linked to renal cell carcinoma.